Preoperative (neoadjuvant) therapy with tislelizumab for locally advanced colorectal cancer with high microsatellite instability or deficient mismatch repair: An open-label, single-arm, multicenter phase II study.

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Journal of Clinical Oncology

Topics

Chemistry

Biochemistry

Medicine

Cancer Oncology

Internal Medicine

Show all topics

DOI

10.1200/jco.2024.42.16_suppl.3599